Searchable abstracts of presentations at key conferences in endocrinology

ea0029oc3.4 | Diabetes Clinical | ICEECE2012

Glucose lowering therapies and cancer specific mortality in adult insulin-treated diabetes

Ioacara S. , Guja C. , Ionescu-Tirgoviste C. , Fica S. , Martin S. , Sabau S. , Tiu C.

Aim: Following the general concern regarding the association between various diabetes treatments and cancer risk, the present study evaluated the cancer specific mortality in adult insulin-treated diabetes patients.Materials and methods: All diabetes patients residing in a major urban area, aged over 40 years and receiving insulin treatment were included at the moment of their first diabetes outpatient visit from 01/01/2001 to 12/31/2008. A total of 1136...

ea0029p1727 | Thyroid (non-cancer) | ICEECE2012

Does serum inflammatory and cytokine profile influence graves disease severity at diagnosis?

Martin S. , Sirbu A. , Fica S.

Introduction: Autoimmune thyroid disease affects 1% of the population and comprises several disorders, including GravesÂ’ disease(GD). Local and serum cytokines are increased in patients with Graves disease, play a central role in co-ordinating immune reactions and have immunolgical and functional effects on thyroid cells.Aim: To investigate serum inflammatory and cytokines profile in untreated patients with GravesÂ’ disease at diagnosis, when th...

ea0005p170 | Growth and Development | BES2003

Regulation of Wolffian duct development in patients with complete androgen insensitivity syndrome

Hannema S , Martin H , Hughes I

Wolffian duct (WD) development is believed to be testosterone dependent. However, patients with complete androgen insensitivity syndrome (CAIS) and a causative mutation in the androgen receptor (AR) still develop WDs. Exceptions to this observation are those patients with severe N-terminal mutations. We investigated the role of the AR in WD development in these patients.AR expression in genital skin fibroblasts (GSF) from eleven patients with CAIS was studied by Western hy...

ea0094p66 | Metabolism, Obesity and Diabetes | SFEBES2023

Developing flare-responsive intra-articular steroid injections

Crastin Ana , S. Martin Claire , Sagmeister Michael , V. Adcock Holly , R. Adams Holly , Raza Karim , Filer Andrew , J. A. Moakes Richard , M. Grover Liam , S. Hardy Rowan

Intra-articular (IA) glucocorticoids (GCs) injections are effective in controlling joint inflammation but limited by short duration of action and off-target side effects. Gellan sheared hydrogels (SHs) area drug delivery vehicle, with unique thinning properties and enhanced release kinetics. We hypothesise that a combination of SHs and pre-receptor metabolism activated GCs provide slow-release drug delivery to target inflammation and minimise side-effects. We the release kinet...